Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
Immunocore Holdings plc (NASDAQ: IMCR)
IMCR Stock Predictions and Ratings
WSX Rating:
BUY
WSX Forecast (1yr):
6.20%
Analyst Rating:
BUY
Analyst Forecast (1yr):
141.20%
IMCR Stock Analysis
IMCR
PE Ratio:
IMCR
PEG Ratio:
Not Available
IMCR
Forward EPS Growth (12 month):
0.00%
IMCR
PS Ratio:
3.5
IMCR
PSG Ratio:
0.4
IMCR
Forward Revenue Growth (12 month):
9.40%
IMCR Articles
No data was found